D. Edgeworth

Attitudes of Irish patients with chronic pain towards medicinal cannabis

D. Harmon, C. Rochford, D. Edgeworth, 2019, Irish Journal of Medical Science (1971 -).

Improvement in exercise duration, lung function and well-being in G551D-cystic fibrosis patients: a double-blind, placebo-controlled, randomized, cross-over study with ivacaftor treatment.

T. Kotsimbos, A. Tierney, B. Button, 2017, Clinical science.

Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension.

T. Kotsimbos, A. Tierney, B. Button, 2021, Nutrition.

Patient’s perceptions of physical examination in the setting of chronic pain

D. Harmon, J. Saunders, M. Hashim, 2020, Irish Journal of Medical Science (1971 -).

Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition.

T. Kotsimbos, John W. Wilson, J. Choo, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

ePS03.4 Patient reported adherence to ivacaftor

T. Kotsimbos, A. Tierney, B. Button, 2015 .

ePS05.3 Ivacaftor and its effects on body composition in adults with G551D related cystic fibrosis

T. Kotsimbos, A. Tierney, B. Button, 2015 .

WS09.5 Effect of ivacaftor on wellness, quality of life and cognitive function in adults with cystic fibrosis and G551D mutation

T. Kotsimbos, A. Tierney, B. Button, 2015 .

73 The effect of ivacaftor CFTR gene-potentiating therapy on cytokine levels in CF patients with the G551D mutation

T. Kotsimbos, N. Mifsud, John W. Wilson, 2017 .